News

Sarepta shares fall 37% as FDA questions future of key gene therapy
Sarepta Therapeutics shares plunge over 37% as FDA weighs halting shipments of its key gene therapy, Elevidys, after patient ...
FDA to Ask Sarepta to Halt Elevidys Shipments After Deaths
The Food and Drug Administration plans to ask Sarepta Therapeutics Inc. to pause shipments of its Elevidys treatment after ...
CNBCTV1828m
US Stock Market LIVE Updates: Dow falls 200 points after report says Trump pushing for at least a 15% tariff on EU imports
US stock futures rose slightly on Friday (July 18) after the S&P 500 closed at a record high in the previous session, with ...